Cell Therapeutics, Inc. (CTIC)

Last Year

28-Apr-23 -- 27-Apr-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drug Manufacturers - Other

Drugs

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

6

(1)

20

0

0

+1

0

+2

0

+3

Two Year Chart

28-Apr-22 -- 27-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
26-Jun-23 4:05 PM View:	26-Jun-23 Disposition (change in control) $442.62K	Tuckson Reed Vaughn Director		Cell Therapeutics, Inc. - CTIC	(100%) 48.64K to 0	0	0	--	--	Show Txns Hide Txns

26-Jun-23 4:05 PM View:	26-Jun-23 Disposition (change in control) $159.68K	Kirske David EVP, Chief Financial Officer		Cell Therapeutics, Inc. - CTIC	(100%) 17.55K to 0	0	0	--	--	Show Txns Hide Txns

26-Jun-23 4:05 PM View:	26-Jun-23 Disposition (change in control) $286.38K	Craig Adam R President and CEO Director		Cell Therapeutics, Inc. - CTIC	(100%) 31.47K to 0	0	0	--	--	Show Txns Hide Txns

26-Jun-23 4:05 PM View:	26-Jun-23 Disposition (change in control) $392.56K	Perry Matthew D Director		Cell Therapeutics, Inc. - CTIC	(100%) 43.14K to 0	0	0	--	--	Show Txns Hide Txns

28-Jun-23 6:26 PM View:	26-Jun-23 Disposition (change in control) $14.28M	Bvf Partners L P/il Director 10% Owner		Cell Therapeutics, Inc. - CTIC	(100%) 8.86M to 0	0	0	--	--	Show Txns Hide Txns

26-Jun-23 4:05 PM View:	26-Jun-23 Disposition (change in control) $32.44K	Fong James K EVP & Chief Commercial Officer		Cell Therapeutics, Inc. - CTIC	(100%) 3.56K to 0	0	0	--	--	Show Txns Hide Txns